Global Ventricular Assist Device Market Insights and Forecast to 2027

SKU ID : QYR- 18049695

Publishing Date : 20-Apr-2021

No. of pages : 112

PRICE
4900
7350
9800

  • Ventricular assist devices are mechanical pumps used to support cardiac circulation in patients who have weakened hearts.

    A ventricular assist device (VAD) is an electromechanical device for assisting cardiac circulation, which is used either to partially or to completely replace the function of a failing heart. The function of VADs is different from that of artificial cardiac pacemakers; some are for short-term use, typically for patients recovering from myocardial infarction (heart attack) and for patients recovering from cardiac surgery; some are for long-term use (months to years to perpetuity), typically for patients suffering from advanced heart failure.
    The major factors that drive the growth of the global ventricular assist devices market include increase in incidence of patients with heart failure and shortage of heart donors. In accordance with the estimates of the American Heart Association, approximately 5.5 million individuals are affected by heart failure in the U.S. In addition, in the U.S., approximately 670,000 new cases of heart failure are diagnosed each year. Moreover, it is estimated that in the U.S., approximately 5.7 million patients of age 20 are affected with heart failure, while 30% of patients are below the age of 60.

    Market Analysis and Insights: Global Ventricular Assist Device Market
    The global Ventricular Assist Device market is valued at US$ XX million in 2019. The market size will reach US$ XX million by the end of 2026, growing at a CAGR of XX% during 2021-2026.

    Global Ventricular Assist Device Scope and Market Size
    Ventricular Assist Device market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Ventricular Assist Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    LVADs
    RVADs
    BIVADs

    Segment by Application
    Bridge-to-transplant (BTT)
    Destination Therapy (DT)
    Other

    By Company
    AbioMed
    Abbott (Thoratec)
    Medtronic (HeartWare)
    Berlin Heart

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports